ProCE Banner Activity

The Importance of Molecular Testing in NSCLC

Slideset Download
Download these slides from a live webinar for the most recent data on the best methods for molecular testing in NSCLC, including information on different testing methodologies, platforms, and assays as well as considerations for clinical practices and socioeconomic disparities.

Released: June 05, 2022

Begin Activity

Share

Faculty

Narjust Duma

Narjust Duma, MD

Associate Director of the Cancer Care Equity Program
Thoracic Oncologist
The Lowe Center for Thoracic Oncology
Dana-Farber Cancer Institute
Brigham and Women’s Hospital
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Lilly

Novartis Pharmaceuticals Corporation

Turning Point Therapeutics Inc

Faculty Disclosure

Primary Author

Narjust Duma, MD

Associate Director of the Cancer Care Equity Program
Thoracic Oncologist
The Lowe Center for Thoracic Oncology
Dana-Farber Cancer Institute
Brigham and Women’s Hospital
Boston, Massachusetts

Narjust Duma, MD, has disclosed that she has received consulting fees from AstraZeneca, BMS, DSI, Merck, Mirati, Neogenomics, and Pfizer.